At 4:44 am (0844 GMT), Grifols was trading 2.6% higher at €9.105. The proposed take-private deal would involve refinancing ...

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...

worth around €7 billion ($7.4 billion). That is below Grifols' current share price of around €11, and well shy of its near-€15 share price at the start of the year, ahead of a campaign by ...

Grifols has been awarded a $21m grant from the ... Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

(Bloomberg) -- Brookfield Asset Management is in talks with several investment funds to join its bid to acquire Spanish blood-plasma company Grifols SA, according to people familiar with the matter.

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Grifols’ repository of PD plasma samples is just a fraction ... with the provisions of the following Spanish legislation: Royal Legislative Decree 4/2015, of 23 October, approving recast text of ...

In the letter, Mason urges the CNMV to consider the benefits to all Grifols shareholders from improved disclosure around several key issues, including: The full text of the letter follows: Comisión ...